CN113705585A - 基于神经网络实现的方法和系统 - Google Patents
基于神经网络实现的方法和系统 Download PDFInfo
- Publication number
- CN113705585A CN113705585A CN202111113164.1A CN202111113164A CN113705585A CN 113705585 A CN113705585 A CN 113705585A CN 202111113164 A CN202111113164 A CN 202111113164A CN 113705585 A CN113705585 A CN 113705585A
- Authority
- CN
- China
- Prior art keywords
- training
- sequence
- pair
- amino acid
- benign
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 90
- 238000013528 artificial neural network Methods 0.000 title abstract description 66
- 238000012549 training Methods 0.000 claims abstract description 251
- 150000001413 amino acids Chemical class 0.000 claims abstract description 114
- 230000000295 complement effect Effects 0.000 claims abstract description 50
- 239000011159 matrix material Substances 0.000 claims abstract description 32
- 230000000153 supplemental effect Effects 0.000 claims abstract description 21
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 8
- 230000007918 pathogenicity Effects 0.000 claims description 55
- 241000288906 Primates Species 0.000 claims description 40
- 238000003860 storage Methods 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 9
- 238000013507 mapping Methods 0.000 claims description 5
- 238000004590 computer program Methods 0.000 claims description 4
- 230000001364 causal effect Effects 0.000 claims description 2
- 230000001717 pathogenic effect Effects 0.000 abstract description 40
- 238000005516 engineering process Methods 0.000 abstract description 29
- 230000008569 process Effects 0.000 abstract description 23
- 239000000523 sample Substances 0.000 description 110
- 238000012163 sequencing technique Methods 0.000 description 61
- 125000003729 nucleotide group Chemical group 0.000 description 58
- 238000013527 convolutional neural network Methods 0.000 description 56
- 239000002773 nucleotide Substances 0.000 description 54
- 108700028369 Alleles Proteins 0.000 description 36
- 150000007523 nucleic acids Chemical group 0.000 description 33
- 241000894007 species Species 0.000 description 31
- 108090000623 proteins and genes Proteins 0.000 description 29
- 108020004705 Codon Proteins 0.000 description 28
- 238000013135 deep learning Methods 0.000 description 27
- 108020004707 nucleic acids Proteins 0.000 description 25
- 102000039446 nucleic acids Human genes 0.000 description 25
- 230000006870 function Effects 0.000 description 23
- 230000035772 mutation Effects 0.000 description 22
- 210000000349 chromosome Anatomy 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 19
- 230000002068 genetic effect Effects 0.000 description 18
- 239000012634 fragment Substances 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 16
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 14
- 241000282577 Pan troglodytes Species 0.000 description 14
- 241000282412 Homo Species 0.000 description 13
- 210000002569 neuron Anatomy 0.000 description 13
- 238000006467 substitution reaction Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000004422 calculation algorithm Methods 0.000 description 11
- 239000002904 solvent Substances 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 238000010801 machine learning Methods 0.000 description 9
- 102000054765 polymorphisms of proteins Human genes 0.000 description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 238000001994 activation Methods 0.000 description 8
- 230000003321 amplification Effects 0.000 description 8
- 238000003776 cleavage reaction Methods 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 230000007017 scission Effects 0.000 description 8
- 241000124008 Mammalia Species 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 230000010339 dilation Effects 0.000 description 7
- 230000000306 recurrent effect Effects 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- 208000037170 Delayed Emergence from Anesthesia Diseases 0.000 description 6
- 241000282579 Pan Species 0.000 description 6
- 230000003044 adaptive effect Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000002939 deleterious effect Effects 0.000 description 6
- 230000015654 memory Effects 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 238000010606 normalization Methods 0.000 description 6
- 238000005457 optimization Methods 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 102000054766 genetic haplotypes Human genes 0.000 description 4
- 230000007614 genetic variation Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 3
- 108091093088 Amplicon Proteins 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 238000000585 Mann–Whitney U test Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 238000007635 classification algorithm Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000013136 deep learning model Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- -1 e.g. Proteins 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003278 mimic effect Effects 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000000392 somatic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 2
- 206010069754 Acquired gene mutation Diseases 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 108091092878 Microsatellite Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000013213 extrapolation Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 210000003917 human chromosome Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002887 multiple sequence alignment Methods 0.000 description 2
- 238000013188 needle biopsy Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 238000011176 pooling Methods 0.000 description 2
- 230000004853 protein function Effects 0.000 description 2
- 230000009145 protein modification Effects 0.000 description 2
- 238000012175 pyrosequencing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000007841 sequencing by ligation Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000037439 somatic mutation Effects 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- PHIYHIOQVWTXII-UHFFFAOYSA-N 3-amino-1-phenylpropan-1-ol Chemical compound NCCC(O)C1=CC=CC=C1 PHIYHIOQVWTXII-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101000741396 Chlamydia muridarum (strain MoPn / Nigg) Probable oxidoreductase TC_0900 Proteins 0.000 description 1
- 101000741399 Chlamydia pneumoniae Probable oxidoreductase CPn_0761/CP_1111/CPj0761/CpB0789 Proteins 0.000 description 1
- 101000741400 Chlamydia trachomatis (strain D/UW-3/Cx) Probable oxidoreductase CT_610 Proteins 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 201000006347 Intellectual Disability Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001647769 Mirza Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000995070 Nirvana Species 0.000 description 1
- 241000282576 Pan paniscus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000288935 Platyrrhini Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 101150044878 US18 gene Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000003485 founder effect Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 231100000221 frame shift mutation induction Toxicity 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 241001515942 marmosets Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000003058 natural language processing Methods 0.000 description 1
- 238000003062 neural network model Methods 0.000 description 1
- 230000001123 neurodevelopmental effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/08—Learning methods
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F18/00—Pattern recognition
- G06F18/20—Analysing
- G06F18/24—Classification techniques
- G06F18/241—Classification techniques relating to the classification model, e.g. parametric or non-parametric approaches
- G06F18/2413—Classification techniques relating to the classification model, e.g. parametric or non-parametric approaches based on distances to training or reference patterns
- G06F18/24133—Distances to prototypes
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N20/00—Machine learning
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/04—Architecture, e.g. interconnection topology
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/04—Architecture, e.g. interconnection topology
- G06N3/045—Combinations of networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/08—Learning methods
- G06N3/084—Backpropagation, e.g. using gradient descent
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V10/00—Arrangements for image or video recognition or understanding
- G06V10/40—Extraction of image or video features
- G06V10/44—Local feature extraction by analysis of parts of the pattern, e.g. by detecting edges, contours, loops, corners, strokes or intersections; Connectivity analysis, e.g. of connected components
- G06V10/443—Local feature extraction by analysis of parts of the pattern, e.g. by detecting edges, contours, loops, corners, strokes or intersections; Connectivity analysis, e.g. of connected components by matching or filtering
- G06V10/449—Biologically inspired filters, e.g. difference of Gaussians [DoG] or Gabor filters
- G06V10/451—Biologically inspired filters, e.g. difference of Gaussians [DoG] or Gabor filters with interaction between the filter responses, e.g. cortical complex cells
- G06V10/454—Integrating the filters into a hierarchical structure, e.g. convolutional neural networks [CNN]
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V10/00—Arrangements for image or video recognition or understanding
- G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
- G06V10/82—Arrangements for image or video recognition or understanding using pattern recognition or machine learning using neural networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/30—Detection of binding sites or motifs
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N20/00—Machine learning
- G06N20/20—Ensemble learning
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/04—Architecture, e.g. interconnection topology
- G06N3/044—Recurrent networks, e.g. Hopfield networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/04—Architecture, e.g. interconnection topology
- G06N3/048—Activation functions
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/08—Learning methods
- G06N3/082—Learning methods modifying the architecture, e.g. adding, deleting or silencing nodes or connections
Landscapes
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Evolutionary Computation (AREA)
- Molecular Biology (AREA)
- Data Mining & Analysis (AREA)
- Artificial Intelligence (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- General Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biotechnology (AREA)
- Software Systems (AREA)
- General Engineering & Computer Science (AREA)
- Computing Systems (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Mathematical Physics (AREA)
- Computational Linguistics (AREA)
- Genetics & Genomics (AREA)
- Databases & Information Systems (AREA)
- Bioethics (AREA)
- Multimedia (AREA)
- Biodiversity & Conservation Biology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Image Analysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Machine Translation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
USPCT/US2018/055881 | 2018-10-15 | ||
US16/160,968 US11798650B2 (en) | 2017-10-16 | 2018-10-15 | Semi-supervised learning for training an ensemble of deep convolutional neural networks |
PCT/US2018/055878 WO2019079180A1 (en) | 2017-10-16 | 2018-10-15 | NEURONAL NETWORKS WITH DEEP CONVOLUTION OF VARIANT CLASSIFICATION |
US16/160,903 US10423861B2 (en) | 2017-10-16 | 2018-10-15 | Deep learning-based techniques for training deep convolutional neural networks |
PCT/US2018/055840 WO2019079166A1 (en) | 2017-10-16 | 2018-10-15 | TECHNIQUES BASED ON DEEP LEARNING LEARNING OF NEURONAL NETWORKS WITH DEEP CONVOLUTION |
US16/160,986 US11315016B2 (en) | 2017-10-16 | 2018-10-15 | Deep convolutional neural networks for variant classification |
US16/160903 | 2018-10-15 | ||
USPCT/US2018/055878 | 2018-10-15 | ||
PCT/US2018/055881 WO2019079182A1 (en) | 2017-10-16 | 2018-10-15 | SEMI-SUPERVISED APPRENTICESHIP FOR THE LEARNING OF A SET OF NEURONAL NETWORKS WITH DEEP CONVOLUTION |
US16/160986 | 2018-10-15 | ||
US16/160968 | 2018-10-15 | ||
USPCT/US2018/055840 | 2018-10-15 | ||
US16/407149 | 2019-05-08 | ||
US16/407,149 US10540591B2 (en) | 2017-10-16 | 2019-05-08 | Deep learning-based techniques for pre-training deep convolutional neural networks |
CN201980003263.9A CN111328419B (zh) | 2018-10-15 | 2019-05-09 | 基于神经网络实现的方法和系统 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201980003263.9A Division CN111328419B (zh) | 2018-10-15 | 2019-05-09 | 基于神经网络实现的方法和系统 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113705585A true CN113705585A (zh) | 2021-11-26 |
Family
ID=70283180
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201980003263.9A Active CN111328419B (zh) | 2018-10-15 | 2019-05-09 | 基于神经网络实现的方法和系统 |
CN202111113164.1A Pending CN113705585A (zh) | 2018-10-15 | 2019-05-09 | 基于神经网络实现的方法和系统 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201980003263.9A Active CN111328419B (zh) | 2018-10-15 | 2019-05-09 | 基于神经网络实现的方法和系统 |
Country Status (8)
Country | Link |
---|---|
JP (3) | JP6888123B2 (he) |
KR (1) | KR102165734B1 (he) |
CN (2) | CN111328419B (he) |
AU (2) | AU2019272062B2 (he) |
IL (2) | IL282689B1 (he) |
NZ (1) | NZ759665A (he) |
SG (2) | SG10202108013QA (he) |
WO (1) | WO2020081122A1 (he) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109543761B (zh) * | 2018-11-27 | 2020-07-07 | 成都工业学院 | 植物适生地的分类方法及装置 |
US11443832B2 (en) | 2019-03-07 | 2022-09-13 | Nvidia Corporation | Genetic mutation detection using deep learning |
KR102418073B1 (ko) * | 2020-06-08 | 2022-07-06 | 고려대학교 산학협력단 | 인공지능 기반 비디오 투시 연하검사 자동화 분석 장치 및 방법 |
CN111830408B (zh) * | 2020-06-23 | 2023-04-18 | 朗斯顿科技(北京)有限公司 | 一种基于边缘计算和深度学习的电机故障诊断系统及方法 |
CN112003735B (zh) * | 2020-07-28 | 2021-11-09 | 四川大学 | 一种感知风险的深度学习驱动的极限传输容量调整方法 |
CN112183088B (zh) * | 2020-09-28 | 2023-11-21 | 云知声智能科技股份有限公司 | 词语层级确定的方法、模型构建方法、装置及设备 |
KR102279056B1 (ko) * | 2021-01-19 | 2021-07-19 | 주식회사 쓰리빌리언 | 지식전이를 이용한 유전자변이의 병원성 예측 시스템 |
CN113299345B (zh) * | 2021-06-30 | 2024-05-07 | 中国人民解放军军事科学院军事医学研究院 | 病毒基因分类的方法、装置及电子设备 |
CN113539354B (zh) * | 2021-07-19 | 2023-10-27 | 浙江理工大学 | 一种高效预测革兰氏阴性菌ⅲ型和ⅳ型效应蛋白的方法 |
CN113822342B (zh) * | 2021-09-02 | 2023-05-30 | 湖北工业大学 | 一种安全图卷积网络的文献分类方法及系统 |
CN113836892B (zh) * | 2021-09-08 | 2023-08-08 | 灵犀量子(北京)医疗科技有限公司 | 样本量数据提取方法、装置、电子设备及存储介质 |
CN113963746B (zh) * | 2021-09-29 | 2023-09-19 | 西安交通大学 | 一种基于深度学习的基因组结构变异检测系统及方法 |
US20240087683A1 (en) * | 2022-09-14 | 2024-03-14 | Microsoft Technology Licensing, Llc | Classification using a machine learning model trained with triplet loss |
CN115662520B (zh) * | 2022-10-27 | 2023-04-14 | 黑龙江金域医学检验实验室有限公司 | Bcr/abl1融合基因的检测方法及相关设备 |
CN116153396A (zh) * | 2023-04-21 | 2023-05-23 | 鲁东大学 | 一种基于迁移学习的非编码变异预测方法 |
CN117688785B (zh) * | 2024-02-02 | 2024-04-16 | 东北大学 | 一种基于种植思想的全张量重力梯度数据反演方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160357903A1 (en) * | 2013-09-20 | 2016-12-08 | University Of Washington Through Its Center For Commercialization | A framework for determining the relative effect of genetic variants |
CN107710185A (zh) * | 2015-06-22 | 2018-02-16 | 康希尔公司 | 预测基因序列变异的致病性的方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2044616A1 (en) | 1989-10-26 | 1991-04-27 | Roger Y. Tsien | Dna sequencing |
US5641658A (en) | 1994-08-03 | 1997-06-24 | Mosaic Technologies, Inc. | Method for performing amplification of nucleic acid with two primers bound to a single solid support |
EP0975802B1 (en) | 1997-04-01 | 2004-06-23 | Manteia S.A. | Method of nucleic acid sequencing |
AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
GB0006153D0 (en) * | 2000-03-14 | 2000-05-03 | Inpharmatica Ltd | Database |
CA2415897A1 (en) | 2000-07-07 | 2002-01-17 | Susan H. Hardin | Real-time sequence determination |
WO2002044425A2 (en) | 2000-12-01 | 2002-06-06 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
AR031640A1 (es) | 2000-12-08 | 2003-09-24 | Applied Research Systems | Amplificacion isotermica de acidos nucleicos en un soporte solido |
US7057026B2 (en) | 2001-12-04 | 2006-06-06 | Solexa Limited | Labelled nucleotides |
US20040002090A1 (en) | 2002-03-05 | 2004-01-01 | Pascal Mayer | Methods for detecting genome-wide sequence variations associated with a phenotype |
US7541444B2 (en) | 2002-08-23 | 2009-06-02 | Illumina Cambridge Limited | Modified nucleotides |
CN101914620B (zh) | 2004-09-17 | 2014-02-12 | 加利福尼亚太平洋生命科学公司 | 核酸测序的方法 |
GB0427236D0 (en) | 2004-12-13 | 2005-01-12 | Solexa Ltd | Improved method of nucleotide detection |
AU2006259565B2 (en) | 2005-06-15 | 2011-01-06 | Complete Genomics, Inc. | Single molecule arrays for genetic and chemical analysis |
GB0514910D0 (en) | 2005-07-20 | 2005-08-24 | Solexa Ltd | Method for sequencing a polynucleotide template |
US7405281B2 (en) | 2005-09-29 | 2008-07-29 | Pacific Biosciences Of California, Inc. | Fluorescent nucleotide analogs and uses therefor |
GB0522310D0 (en) | 2005-11-01 | 2005-12-07 | Solexa Ltd | Methods of preparing libraries of template polynucleotides |
US20080009420A1 (en) | 2006-03-17 | 2008-01-10 | Schroth Gary P | Isothermal methods for creating clonal single molecule arrays |
EP2018622B1 (en) | 2006-03-31 | 2018-04-25 | Illumina, Inc. | Systems for sequence by synthesis analysis |
US7754429B2 (en) | 2006-10-06 | 2010-07-13 | Illumina Cambridge Limited | Method for pair-wise sequencing a plurity of target polynucleotides |
EP2089517A4 (en) | 2006-10-23 | 2010-10-20 | Pacific Biosciences California | POLYMERASEENZYME AND REAGENTS FOR ADVANCED NUCKIC ACID SEQUENCING |
NZ590851A (en) * | 2008-07-16 | 2012-08-31 | Dana Farber Cancer Inst Inc | Signatures and pcdeterminants associated with prostate cancer and methods of use thereof |
EP2335175B1 (en) * | 2008-10-02 | 2018-01-10 | Koninklijke Philips N.V. | Method of determining a reliability indicator for signatures obtained from clinical data and use of the reliability indicator for favoring one signature over the other |
JP5773406B2 (ja) | 2010-07-28 | 2015-09-02 | 学校法人明治大学 | Gpiアンカー型タンパク質の判定装置、判定方法及び判定プログラム |
EP2663656B1 (en) | 2011-01-13 | 2016-08-24 | Decode Genetics EHF | Genetic variants as markers for use in urinary bladder cancer risk assessment |
EP3194627B1 (en) | 2014-09-18 | 2023-08-16 | Illumina, Inc. | Methods and systems for analyzing nucleic acid sequencing data |
US20190136248A1 (en) * | 2015-05-15 | 2019-05-09 | Pioneer Hi-Bred International, Inc. | Novel guide rna/cas endonuclease systems |
JP2017151679A (ja) | 2016-02-24 | 2017-08-31 | コニカミノルタ株式会社 | 識別装置及び識別プログラム |
CN107622182B (zh) * | 2017-08-04 | 2020-10-09 | 中南大学 | 蛋白质局部结构特征的预测方法及系统 |
CN108197427B (zh) * | 2018-01-02 | 2020-09-04 | 山东师范大学 | 基于深度卷积神经网络的蛋白质亚细胞定位方法和装置 |
CN108595909A (zh) * | 2018-03-29 | 2018-09-28 | 山东师范大学 | 基于集成分类器的ta蛋白靶向预测方法 |
-
2019
- 2019-05-09 WO PCT/US2019/031621 patent/WO2020081122A1/en active Search and Examination
- 2019-05-09 SG SG10202108013QA patent/SG10202108013QA/en unknown
- 2019-05-09 CN CN201980003263.9A patent/CN111328419B/zh active Active
- 2019-05-09 SG SG11201911777QA patent/SG11201911777QA/en unknown
- 2019-05-09 IL IL282689A patent/IL282689B1/he unknown
- 2019-05-09 AU AU2019272062A patent/AU2019272062B2/en active Active
- 2019-05-09 KR KR1020197038080A patent/KR102165734B1/ko active IP Right Grant
- 2019-05-09 JP JP2019567603A patent/JP6888123B2/ja active Active
- 2019-05-09 CN CN202111113164.1A patent/CN113705585A/zh active Pending
- 2019-05-09 NZ NZ759665A patent/NZ759665A/en unknown
- 2019-12-02 IL IL271091A patent/IL271091B/he active IP Right Grant
-
2021
- 2021-05-19 JP JP2021084634A patent/JP7200294B2/ja active Active
- 2021-11-17 AU AU2021269351A patent/AU2021269351B2/en active Active
-
2022
- 2022-12-21 JP JP2022204685A patent/JP7515559B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160357903A1 (en) * | 2013-09-20 | 2016-12-08 | University Of Washington Through Its Center For Commercialization | A framework for determining the relative effect of genetic variants |
CN107710185A (zh) * | 2015-06-22 | 2018-02-16 | 康希尔公司 | 预测基因序列变异的致病性的方法 |
Non-Patent Citations (1)
Title |
---|
LAKSSHMAN SUNDARAM 等: "Predicting the clinical impact of human mutation with deep neural networks", NATURE GENETICS, 31 August 2018 (2018-08-31), pages 1161 - 1170, XP093031564, DOI: 10.1038/s41588-018-0167-z * |
Also Published As
Publication number | Publication date |
---|---|
JP2021152907A (ja) | 2021-09-30 |
JP2023052011A (ja) | 2023-04-11 |
NZ759665A (en) | 2022-07-01 |
SG10202108013QA (en) | 2021-09-29 |
IL271091A (he) | 2020-04-30 |
CN111328419B (zh) | 2021-10-19 |
IL282689B1 (he) | 2024-10-01 |
AU2019272062A1 (en) | 2020-04-30 |
JP7200294B2 (ja) | 2023-01-06 |
AU2021269351B2 (en) | 2023-12-14 |
AU2021269351A1 (en) | 2021-12-09 |
IL282689A (he) | 2021-06-30 |
SG11201911777QA (en) | 2020-05-28 |
JP6888123B2 (ja) | 2021-06-16 |
AU2019272062B2 (en) | 2021-08-19 |
IL271091B (he) | 2021-05-31 |
WO2020081122A1 (en) | 2020-04-23 |
KR102165734B1 (ko) | 2020-10-14 |
JP7515559B2 (ja) | 2024-07-12 |
JP2021501923A (ja) | 2021-01-21 |
KR20200044731A (ko) | 2020-04-29 |
CN111328419A (zh) | 2020-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111328419B (zh) | 基于神经网络实现的方法和系统 | |
EP3659143B1 (en) | Deep learning-based techniques for pre-training deep convolutional neural networks | |
US10540591B2 (en) | Deep learning-based techniques for pre-training deep convolutional neural networks | |
JP7247253B2 (ja) | 経験的バリアントスコア(evs)ベースの深層学習バリアントコーラ | |
US12073922B2 (en) | Deep learning-based framework for identifying sequence patterns that cause sequence-specific errors (SSEs) | |
CN110832597A (zh) | 基于深度神经网络的变体分类器 | |
AU2019272065B2 (en) | Deep learning-based framework for identifying sequence patterns that cause sequence-specific errors (SSEs) | |
CA3064223A1 (en) | Deep learning-based techniques for pre-training deep convolutional neural networks | |
NZ788839A (en) | Deep learning-based techniques for pre-training deep convolutional neural networks | |
NZ791625A (en) | Variant classifier based on deep neural networks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |